CNS & Neurological Disorders - Drug Targets
Title:Conference Report [IANR V and 9th GCNN Conference with 4th ISCITT Symposium]
Volume: 11 Issue: 6
Author(s): Zikuan Leng, Lei Guo, Hari Shanker Sharma, Hongyun Huang and Xijing He
Affiliation:
Export Options
About this article
Cite this article as:
Leng Zikuan, Guo Lei, Shanker Sharma Hari, Huang Hongyun and He Xijing, Conference Report [IANR V and 9th GCNN Conference with 4th ISCITT Symposium], CNS & Neurological Disorders - Drug Targets 2012; 11 (6) . https://dx.doi.org/10.2174/187152712803581083
DOI https://dx.doi.org/10.2174/187152712803581083 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Preclinical Models of Graves’ Disease and Associated Secondary Complications
Current Pharmaceutical Design Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets Pathophysiology of Airway Colonization in Critically ill COPD Patient
Current Drug Targets Recent Gains in Clinical Multiple Sclerosis Research
CNS & Neurological Disorders - Drug Targets Targeting Oxidative Stress Component in the Therapeutics of Epilepsy
Current Topics in Medicinal Chemistry Mitochondrial Biology and Neurological Diseases
Current Neuropharmacology Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity
Current Medicinal Chemistry The Risk that DSM-5 will Result in a Misallocation of Scarce Resources
Current Psychiatry Reviews T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions
Endocrine, Metabolic & Immune Disorders - Drug Targets Aggresome Formation and Neurodegenerative Diseases: Therapeutic Implications
Current Medicinal Chemistry Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Current Psychiatry Reviews Unveiling Cancer in IBD: Screening Colonoscopy or Chromoendoscopy
Current Drug Targets RNAi Applications in Therapy Development for Neurodegenerative Disease
Current Pharmaceutical Design Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reviews on Recent Clinical Trials Oxidative Stress and Amyloid Beta Toxicity in Alzheimer’s Disease: Intervention in a Complex Relationship by Antioxidants
Current Medicinal Chemistry Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Current Alzheimer Research The Complex Biology of FOXO
Current Drug Targets Cholesterol and Alzheimers Disease: Clinical and Experimental Models Suggest Interactions of Different Genetic, Dietary and Environmental Risk Factors
Current Drug Targets